Measured Risk Portfolios’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$275K Sell
760
-141
-16% -$48.3K 0.24% 56
2026
Q1
$317K Sell
901
-138
-13% -$49.2K 0.35% 53
2025
Q4
$340K Buy
1,039
+128
+14% +$40.6K 0.34% 55
2025
Q3
$257K Hold
911
– – 0.24% 60
2025
Q2
$254K Hold
911
– – 0.25% 56
2025
Q1
$284K Sell
911
-2
-0.2% -$591 0.3% 52
2024
Q4
$238K Buy
+913
New +$271K 0.25% 58

Other funds holding AMGN

Measured Risk Portfolios's AMGN Position: Q2 2026 in Review

Measured Risk Portfolios reduced its Amgen (AMGN) stake by 16% in Q2 2026, selling an estimated $48.3K and leaving 760 shares worth $275K. The position accounts for 0.24% of the portfolio, ranked #56.

Measured Risk Portfolios first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $340K in Q4 2025. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Measured Risk Portfolios held 760 shares of Amgen worth $275K as of Q2 2026.
  • Measured Risk Portfolios sold 141 Amgen shares in Q2 2026, an estimated $48.3K.
  • Amgen made up 0.24% of Measured Risk Portfolios's portfolio in Q2 2026, its #56 holding.
  • Measured Risk Portfolios first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • Measured Risk Portfolios's Amgen position peaked at $340K in Q4 2025.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Measured Risk Portfolios's 13F filing for Q2 2026, filed 12 Aug 2026.